Literature DB >> 9818546

Chronic rejection and chronic cyclosporin toxicity in renal allografts.

M Pascual1, R D Swinford, J R Ingelfinger, W W Williams, A B Cosimi, N Tolkoff-Rubin.   

Abstract

Recent evidence indicates that growth factors are critically important in both chronic rejection and chronic cyclosporin A toxicity, suggesting that these two entities share a common pathophysiological pathway, leading to progressive allograft failure. Here, Manuel Pascual and colleagues discuss the relevance of growth factors to chronic allograft nephropathy, and the implications for therapy in view of the great choice of immunosuppressive drugs now available.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9818546     DOI: 10.1016/s0167-5699(98)01324-3

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  7 in total

1.  Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus.

Authors:  Darshika Chhabra; Anton I Skaro; Joseph R Leventhal; Pranav Dalal; Gaurav Shah; Edward Wang; Lorenzo Gallon
Journal:  Clin J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 8.237

Review 2.  Chronic allograft nephropathy in paediatric renal transplantation.

Authors:  Stephen I Alexander; Jeffrey T Fletcher; Brian Nankivell
Journal:  Pediatr Nephrol       Date:  2006-08-30       Impact factor: 3.714

3.  The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients.

Authors:  Kyoung Woon Kim; Byung Ha Chung; Bo-Mi Kim; Mi-La Cho; Chul Woo Yang
Journal:  Immunology       Date:  2015-01       Impact factor: 7.397

4.  Autoantibodies against cytochrome P450s in sera of children treated with immunosuppressive drugs.

Authors:  S D Lytton; U Berg; A Nemeth; M Ingelman-Sundberg
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

5.  Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.

Authors:  Sunil M Kurian; Raymond Heilman; Tony S Mondala; Aleksey Nakorchevsky; Johannes A Hewel; Daniel Campbell; Elizabeth H Robison; Lin Wang; Wen Lin; Lillian Gaber; Kim Solez; Hamid Shidban; Robert Mendez; Randolph L Schaffer; Jonathan S Fisher; Stuart M Flechner; Steve R Head; Steve Horvath; John R Yates; Christopher L Marsh; Daniel R Salomon
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

6.  Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.

Authors:  Amgad E El-Agroudy; Khaled F El-Dahshan; Khaled Mahmoud; Amani M Ismail; Mahmoud El-Baz; Ahmed A Shokeir; Mohamed A Ghoneim
Journal:  Clin Exp Nephrol       Date:  2008-08-21       Impact factor: 2.801

7.  RCAN-11R peptide provides immunosuppression for fully mismatched islet allografts in mice.

Authors:  Hirofumi Noguchi; Koji Sugimoto; Chika Miyagi-Shiohira; Yoshiki Nakashima; Naoya Kobayashi; Issei Saitoh; Masami Watanabe; Yasufumi Noguchi
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.